WEIDONG ZHANG
Medical Practice at Tamiami Ave, Tampa, FL
License number
Florida 46055
Issued Date
Apr 9, 2014
Effective Date
Apr 9, 2014
Expiration Date
Aug 31, 2018
Category
Health Care
Type
Clinical Laboratory Personnel
Address
Address
20119 Tamiami Ave, Tampa, FL 33647
Phone
(813) 343-0881
Professional information
Breast Cancer Therapy Using An Engineered Respiratory Syncytial Virus
US Patent:
8597637, Dec 3, 2013
Filed:
May 18, 2010
Appl. No.:
12/800585
Inventors:
Weidong Zhang - Tampa FL, US
Lixian Jiang - Wesley Chapel FL, US
Calvin Cao - Tampa FL, US
Lixian Jiang - Wesley Chapel FL, US
Calvin Cao - Tampa FL, US
International Classification:
A01N 63/00, A01N 65/00, A61K 48/00, C12Q 1/70
US Classification:
424 932, 424 931, 435 5
Abstract:
The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 gene deficient RSV, and its usage to treat breast cancer by killing cancer cells with in vitro and in vivo evidences.
Lung Cancer Therapy Using An Engineered Respiratory Syncytial Virus
US Patent:
2013025, Sep 26, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/790278
Inventors:
Weidong Zhang - Tampa FL, US
Lixian Jiang - Wesley Chapel FL, US
Calvin Cao - Tampa FL, US
Lixian Jiang - Wesley Chapel FL, US
Calvin Cao - Tampa FL, US
Assignee:
CZ BIOMED CORP. - Tampa FL
International Classification:
A61K 35/76
US Classification:
424 932
Abstract:
The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS1 gene deficient RSV, and its usage to treat lung cancer by killing cancer cells with in vitro and in vivo evidences.
Method To Prevent Missing Pcr Template And/Or Reaction Mixture And Its Further Use Of Preventing Missing Solution(S) In Experiment
US Patent:
2012023, Sep 20, 2012
Filed:
Mar 14, 2011
Appl. No.:
13/065094
Inventors:
Fushan Wang - Broomall PA, US
Weidong Zhang - Tampa FL, US
Lixian Jiang - Wesley Chapel FL, US
Weidong Zhang - Tampa FL, US
Lixian Jiang - Wesley Chapel FL, US
International Classification:
C12Q 1/68
US Classification:
435 61
Abstract:
This invention discloses a method by colored solution to prevent missing a solution in experiment.
Polynucleotides For Reducing Respiratory Syncytial Virus Gene Expression
US Patent:
2007023, Oct 11, 2007
Filed:
Dec 6, 2004
Appl. No.:
10/581580
Inventors:
Shyam Mohapatra - Tampa FL, US
Weidong Zhang - Tampa FL, US
Weidong Zhang - Tampa FL, US
International Classification:
A61K 31/70, C07H 21/02
US Classification:
514044000, 435320100, 536023100, 536023200
Abstract:
This invention pertains to polynucleotides, such as small interfering RNA (siRNA), useful for reducing the expression of respiratory syncytial virus (RSV) genes within a subject; and methods for treating a patient suffering from, or at risk of developing, an RSV infection by administering such polynucleotides to the subject.
Polynucleotides For Reducing Respiratory Syncytial Virus Gene Expression
US Patent:
2013021, Aug 22, 2013
Filed:
Feb 13, 2013
Appl. No.:
13/765858
Inventors:
UNIVERSITY OF SOUTH FLORIDA - , US
WEIDONG ZHANG - TAMPA FL, US
WEIDONG ZHANG - TAMPA FL, US
International Classification:
A61K 31/713, C12N 15/113
US Classification:
514 44 A, 536 245
Abstract:
This invention pertains to polynucleotides, such as small interfering RNA (siRNA), useful for reducing the expression of respiratory syncytial virus (RSV) genes within a subject; and methods for treating a patient suffering from, or at risk of developing, an RSV infection by administering such polynucleotides to the subject.